Bacteria News and Research

RSS

Research helps develop new medicines with antibacterial properties

The research, conducted at the CEU UCH, combines molecular typology and QSAR methods as faster and more affordable tools in order to obtain new medicines and challenge the growing appearance of bacterial resistances.

27 Mar 2019

AIDS-immunocompromised populations more likely to see antibiotic-resistant bacterial infections

Populations with a high prevalence of AIDS-immunocompromised people are more likely to see the emergence of antibiotic-resistant bacterial infections, according to a study coauthored by researchers at the University of Tennessee, Knoxville, and published in PLOS One.

27 Mar 2019

LNC Therapeutics announces grant of Cornell University patent relating to christensenella bacteria

LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery, announced today the grant of the Cornell University (Ithaca, New-York, USA) patent relating to christensenella bacteria.

26 Mar 2019

Bacteria may travel thousands of miles through the air worldwide, Rutgers study suggests

Bacteria may travel thousands of miles through the air worldwide instead of hitching rides with people and animals, according to Rutgers and other scientists. Their "air bridge" hypothesis could shed light on how harmful bacteria share antibiotic resistance genes.

26 Mar 2019

Researchers demonstrate drug diversity in bacteria

Bacteria produce a cocktail of various bioactive natural products in order to survive in hostile environments with competing (micro)organisms.

26 Mar 2019

Children’s ball pits full of pathogenic microbes

A new study has found that the ball pits used by children in physical therapy clinics may be colonized with various microorganisms, some of which are pathogenic.

25 Mar 2019

Scientific Symposium at LABVOLUTION focuses on key issues in life sciences

The Scientific Symposium at LABVOLUTION will be focusing on key issues in the life sciences. Accordingly, a high level of visitor demand is anticipated.

From LABVOLUTION 25 Mar 2019

Synthetic peptide appears to disrupt inflammation and protect kidneys from nephritis

A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions, investigators report.

25 Mar 2019

Altering gut microbiome may be potential treatment option for PCOS

Symptoms of polycystic ovary syndrome improved with exposure to healthy bacteria in the gut, according to a study in a mouse model of this common women's endocrine disorder.

25 Mar 2019

Shaping new treatments for tuberculosis

To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.

25 Mar 2019

Special Collection tracks development of new diagnostic tests for tuberculosis

The Cochrane Infectious Diseases Group (link is external) (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis.

25 Mar 2019

Anti-TB drugs can increase susceptibility to Mtb reinfection

Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

22 Mar 2019

Study provides new pathway for controlling inflammation

UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.

22 Mar 2019

New approach to prescribing antibiotics could curb resistance

Researchers at Rice University have proposed a new approach to understanding how to prescribe antibiotics in a way that will help to curb antibiotic resistance.

22 Mar 2019

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

Spontaneous preterm birth, defined as birth before 37 weeks of gestation, and the related complications, are the largest contributors to infant death in the United States and worldwide, according to the World Health Organization.

22 Mar 2019

Presence of bacteria in urine does not always point to infection, shows study

Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

22 Mar 2019

Fluctuating growth rate of bacteria helps it to develop resistance against antibiotic

If an antibiotic doesn't kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

22 Mar 2019

Researchers look for new ways to skirt impressive Gram-negative defense system

Superbugs, also known as Gram-negative bacteria, are causing a global health crisis. Each year in the United States, at least two million people contract an antibiotic-resistant infection, according to the Centers for Disease Control.

22 Mar 2019

Certain bacteria and immune factors in vagina may cause or protect against preterm birth

Seven types of bacteria and certain immune factors in a woman's vagina and cervix may be responsible for increasing the risk of spontaneous preterm birth or protect against it, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and the University of Maryland School of Medicine.

22 Mar 2019

Researchers identify a more effective treatment for cancer

Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy.

22 Mar 2019